# A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

> **NCT00292461** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 64 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Lamotrigine

## Key facts

- **NCT ID:** NCT00292461
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2013-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292461, "A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00292461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*